RED MAPLE TECHNOLOGIES, INC. – Trademark Portfolio
Entity Type: 03
RED MAPLE TECHNOLOGIES, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include RED MAPLE, RED MAPLE PRESS, and RED MAPLE TECHNOLOGIES. The owner is based in Boerne, TX.
108 Oak Park
Boerne, TX 78006
Showing of trademarks Trademarks
Trademark Classifications
RED MAPLE TECHNOLOGIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does RED MAPLE TECHNOLOGIES, INC. have?
RED MAPLE TECHNOLOGIES, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 cancelled.
What trademark classes does RED MAPLE TECHNOLOGIES, INC. file in?
RED MAPLE TECHNOLOGIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are RED MAPLE TECHNOLOGIES, INC.'s most well-known trademarks?
RED MAPLE TECHNOLOGIES, INC.'s registered trademark portfolio includes well-known marks such as RED MAPLE, RED MAPLE PRESS, and RED MAPLE TECHNOLOGIES. These are among 6 currently registered trademarks in the portfolio.
What is RED MAPLE TECHNOLOGIES, INC.'s trademark registration success rate?
RED MAPLE TECHNOLOGIES, INC. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.